Coulter Partners places seasoned financial leader David Hastings as CFO at Trevi Therapeutics
LONDON, UK and CAMBRIDGE, MA – January 13, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for Trevi Therapeutics, Inc. (Nasdaq: TRVI) and is pleased to announce the placement of David Hastings as Chief Financial Officer (CFO).